CDK2-IN-41

• Target :

  Apoptosis|||Reactive Oxygen Species|||ROS|||CDK

• Related Pathways :

  Apoptosis|||Immunology/Inflammation|||NF-?B|||Cell Cycle/Checkpoint|||Metabolism

• Bioactivity :

  CDK2-IN-41 (Compound 7a) is a CDK2 inhibitor that impedes the cell cycle by binding to CDK2, leading to cytotoxicity, increased ROS production, and apoptosis (Apoptosis) . It exhibits anticancer activity with an IC50 of 10 µM against acute myeloid leukemia (AML) HL-60 cells. CDK2-IN-41 is applicable in research related to AML-associated cancers.

• Molecular Formula :

  C19H21N3S

• Molecular Weight :

  323.46

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C